Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Ruhmann

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Arthritis and Rheumatism|January 26, 2012
Endogenous activation of adaptive immunity: tenascin-C drives interleukin-17 synthesis in murine arthritic joint diseaseMichaela Ruhmann, Anna M Piccinini, Philip L Kong, et al.
Critical Reviews in Immunology|May 6, 2011
Expression and immune function of tenascin-CIrina A Udalova, Michaela Ruhmann, Scott J P Thomson, et al.
Plos Pathogens|June 16, 2010
Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBPLenka Skalska, Robert E White, Melanie Franz, et al.
Scandinavian Journal of Child and Adolescent Psychiatry and Psychology|April 30, 2021
Effectiveness and safety of dexamphetamine sulfate (Attentin<sup>®</sup>) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional studyHenrik Uebel-von Sandersleben, Oliver Dangel, Roland Fischer, et al.
Scandinavian Journal of Child and Adolescent Psychiatry and Psychology|November 30, 2023
Pharmacokinetics of a Modified-Release Dexamphetamine Sulfate Formulation Following Single and Multiple Dosing in Healthy Adults: Comparative Bioavailability with Immediate-Release Dexamphetamine Sulfate, between Strengths, Assessment of Food and Meal Composition EffectsHenrik Uebel-von Sandersleben, Anke Mayer, Michaela Ruhmann, et al.
CNS Drugs|December 13, 2024
Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)Yi Zheng, Huaqing Liu, Xiuxia Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 25, 2022
Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trialMarkus Ketteler, Andrzej Wiecek, Alexander R Rosenkranz, et al.
World Journal of Cardiology|May 28, 2016
Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4Azhar Maqbool, Emma J Spary, Iain W Manfield, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Arthritis and Rheumatism|January 26, 2012
Endogenous activation of adaptive immunity: tenascin-C drives interleukin-17 synthesis in murine arthritic joint diseaseMichaela Ruhmann, Anna M Piccinini, Philip L Kong, et al.
Critical Reviews in Immunology|May 6, 2011
Expression and immune function of tenascin-CIrina A Udalova, Michaela Ruhmann, Scott J P Thomson, et al.
Plos Pathogens|June 16, 2010
Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBPLenka Skalska, Robert E White, Melanie Franz, et al.
Scandinavian Journal of Child and Adolescent Psychiatry and Psychology|April 30, 2021
Effectiveness and safety of dexamphetamine sulfate (Attentin<sup>®</sup>) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional studyHenrik Uebel-von Sandersleben, Oliver Dangel, Roland Fischer, et al.
Scandinavian Journal of Child and Adolescent Psychiatry and Psychology|November 30, 2023
Pharmacokinetics of a Modified-Release Dexamphetamine Sulfate Formulation Following Single and Multiple Dosing in Healthy Adults: Comparative Bioavailability with Immediate-Release Dexamphetamine Sulfate, between Strengths, Assessment of Food and Meal Composition EffectsHenrik Uebel-von Sandersleben, Anke Mayer, Michaela Ruhmann, et al.
CNS Drugs|December 13, 2024
Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)Yi Zheng, Huaqing Liu, Xiuxia Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 25, 2022
Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trialMarkus Ketteler, Andrzej Wiecek, Alexander R Rosenkranz, et al.
World Journal of Cardiology|May 28, 2016
Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4Azhar Maqbool, Emma J Spary, Iain W Manfield, et al.
Pageof 1